Porter, J R Brawer, M K
Published in
World journal of urology
Prostatic intraepithelial neoplasia (PIN) is a putative premalignant lesion of the prostate gland. PIN has been demonstrated to share morphologic and phenotypic similarities to invasive carcinoma of the prostate. In addition, PIN is spatially related to invasive carcinoma and occurs with greater frequency in men whose prostates harbor carcinoma. Pr...
Watson, G M Landers, B Nauth-Misir, R Wickham, J E
Published in
World journal of urology
Two stages in the development of the technique of laser lithotripsy are described. In the first series, spanning 1985-1988, three consecutive groups of patients are compared. In the first 100 patients, 11.5-F ureteroscopes were used. Access on first retrograde attempt was successful in 73%; 3% developed strictures; the ureteric perforation rate was...
Oates, R D Amos, J A
Published in
World journal of urology
CF and CBAVD are really just ends of a clinical spectrum. The type and nature of the mutations in the CF gene probably determine the phenotypic expression of the patient. Perhaps all patients homozygous for delta F508, for example, will have severe pulmonary and pancreatic disease as well as absent vasa, whereas those with other combinations, such ...
Sigman, M
Published in
World journal of urology
Laboratory testing is an integral component of the evaluation of the infertile man. This testing must be appropriate and specific for the individual couple. As there are many tests that evaluate various aspects of infertility, the urologist must understand what information the tests can offer as well as the limitations of each assay. The semen anal...
Patard, J J Chopin, D K Boccon-Gibod, L
Published in
World journal of urology
Local immunotherapy with bacillus Calmette-Guérin (BCG) is an effective treatment to prevent recurrence and progression of superficial bladder cancer, but the antitumor mechanism of action of BCG remains unclear. There are some experimental and clinical data suggesting that BCG antigens are processed not only by immunocompetent cells but also by ur...
Semjonow, A Hamm, M Rathert, P
Published in
World journal of urology
The serum half-life of prostate-specific antigen (PSA) calculated subsequent to radical prostatectomy can serve to predict which patients are at high risk of bearing residual prostatic carcinoma despite their initial attainment of undetectable PSA serum levels. This report updates previous results to a mean follow-up period of 37 months. The initia...
Eisenberger, F Schmidt, A
Published in
World journal of urology
Based on optimal efficacy regarding disintegration and stone clearance, combined with minimal invasiveness, extracorporeal shockwave lithotripsy (ESWL) represents the first choice therapy for urolithiasis. Further developments in ESWL have related more to economic aspects than to improvement of disintegration efficacy or reduction of side effects. ...
Cohen, N P Whitfield, H N
Published in
World journal of urology
The ability to predict how easily a stone will break in response to extracorporeal and intracorporeal lithotripsy would be advantageous for the urologist. In a study of fragments from 52 urinary calculi, in vitro microhardness results were found to increase for the series struvite to brushite. Ultrasound velocity measurements performed on 35 intact...
Vleeming, R Noordzij, J W de Reijke, T M Kurth, K H
Published in
World journal of urology
In this prospective study a comparison of 4-versus 7-MHz transrectal ultrasonography for the detection of prostatic carcinoma is reported. A total of 150 prostates were biopsied due to suspicion of malignancy arising at either digital rectal examination, 4- and/or 7-MHz transrectal ultrasonography, or elevated serum prostate-specific antigen levels...
Benson, M C McMahon, D J Cooner, W H Olsson, C A
Published in
World journal of urology
Prostate-specific antigen (PSA) is the most accurate serum marker for cancer of the prostate (CaP). However, its sensitivity and specificity are suboptimal, especially at values ranging between 4.1 and 10.0 ng/ml (monoclonal), because benign prostatic hypertrophy and hyperplasia (BPH) and CaP frequently coexist in this range. This study was underta...